Enzymatica AB (publ) (ENZY.ST)
Enzymatica AB (publ) operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $1.67, down 1.48% on the session, giving a market capitalisation of $404.2M. Its beta of -0.40 implies it has historically moved less than the broad market.
Enzymatica AB, a life science company headquartered in Lund, Sweden, focuses on the development and sale of medical devices for infection-related illnesses. Founded in 2007, its primary offering is the ColdZyme mouth spray, designed to help prevent and reduce the duration of the common cold. The company also produces various enzyme formulations. This mouth spray is distributed across several European markets under different brand names: ViruProtect in Denmark, STADAProtect in Germany, Psysiomer Stop Virus in France, and Zerinol Virus Defense in Italy.
Enzymatica AB (publ) is most often compared with the following Healthcare names: